Bupropion: A new antidepressant drug, the mechanism of action of which is not associated with down-regulation of postsynaptic β-adrenergic, serotonergic (5-HT2), α2-adrenergic, imipramine and dopaminergic receptors in brain
- 1 November 1983
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 22 (11), 1257-1267
- https://doi.org/10.1016/0028-3908(83)90198-3
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Action of mianserin and zimelidine on the norepinephrine receptor coupled adenylate cyclase system in brain: Subsensitivity without reduction in β-adrenergic receptor bindingNeuropharmacology, 1980
- The effect of psychoactive drugs on beta-adrenergic receptor binding sites in rat brainNeuropharmacology, 1980
- MULTIPLE SEROTONIN RECEPTORS - DIFFERENTIAL BINDING OF [5-HYDROXYTRYPTAMINE-H-3, [LYSERGIC-H-3 ACID DIETHYLAMIDE AND [H-3]SPIROPERIDOL1979
- Mode of action of antidepressant drugsBiochemical Pharmacology, 1978
- Desmethylimipramine-induced decrease in β-adrenergic receptor binding in rat cerebral cortexBiochemical Pharmacology, 1978
- EFFECTS OF 6-HYDROXYDOPAMINE ON DEVELOPMENT OF BETA-ADRENERGIC RECEPTOR-ADENYLATE CYCLASE SYSTEM IN RAT CEREBRAL-CORTEX1977
- Alpha-noradrenergic receptor binding in mammalian brain: Differential labeling of agonist and antagonist statesLife Sciences, 1976
- PROPERTIES OF [HALOPERIDOL-H-3] AND [DOPAMINE-H-3] BINDING ASSOCIATED WITH DOPAMINE RECEPTORS IN CALF BRAIN MEMBRANES1976
- BETA-ADRENERGIC RECEPTOR-BINDING IN MEMBRANE PREPARATIONS FROM MAMMALIAN BRAIN1976
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTJournal of Biological Chemistry, 1951